Skip to main content

Table 5 Comparisons of CSFP and CSF AD neuropathological biomarkers according to the ATN framework

From: Association between cerebrospinal fluid pressure and cognition in patients with Alzheimer’s disease and Lewy body dementia

 

A-T-

A + T-

A-T+

A + T+

P value

All patients

N

4

16

28

84

 

CSFP (mmH2O)

161 ± 46.97

129 ± 40.65

130 ± 33.04

114 ± 31.45

0.02

AD

N

 

12

22

71

 

CSFP (mmH2O)

 

137 ± 10.93

129 ± 7.03

117 ± 3.73

0.06

LBD

N

4

4

6

13

 

CSFP (mmH2O)

161 ± 46.97

106 ± 45.34

133 ± 36.19

103 ± 29.75

0.09

  1. In all patients, after Bonferroni corrections, no differences were found between the two groups
  2. ATN, amyloid tau neurodegeneration framework; AD, Alzheimer’s disease; LBD, Lewy body dementia
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us